Literature DB >> 16567891

Helicobacter pylori infection in India: the case against eradication.

B S Ramakrishna1.   

Abstract

Entities:  

Mesh:

Year:  2006        PMID: 16567891

Source DB:  PubMed          Journal:  Indian J Gastroenterol        ISSN: 0254-8860


× No keyword cloud information.
  14 in total

Review 1.  Emerging and re-emerging bacterial diseases in India.

Authors:  T D Chugh
Journal:  J Biosci       Date:  2008-11       Impact factor: 1.826

2.  Exploring current status of Helicobacter pylori infection in different age groups of patients with dyspepsia.

Authors:  Amit K Dutta; Viswanath D Reddy; Venkatkrishnan H Iyer; L S Unnikrishnan; Ashok Chacko
Journal:  Indian J Gastroenterol       Date:  2018-01-24

3.  Sequential therapy versus standard triple-drug therapy for Helicobacter pylori eradication: a randomized study.

Authors:  Mukesh Nasa; Ajay Choksey; Aniruddha Phadke; Prabha Sawant
Journal:  Indian J Gastroenterol       Date:  2013-10-26

4.  Frequency of Helicobacter pylori and CagA antibody in patients with gastric neoplasms and controls: the Indian enigma.

Authors:  Uday C Ghoshal; Shridhar Tiwari; Sadhna Dhingra; Rakesh Pandey; Ujjala Ghoshal; Shweta Tripathi; Himani Singh; V K Gupta; A K Nagpal; Sita Naik; Archana Ayyagari
Journal:  Dig Dis Sci       Date:  2008-03-20       Impact factor: 3.199

5.  Efficacy and safety of sequential therapy versus standard triple therapy in Helicobacter pylori eradication in Kashmir India: a randomized comparative trial.

Authors:  Gul Javid; Showkat Ali Zargar; Khurshid Bhat; Bashir Ahmad Khan; Ghulam Nabi Yatoo; Ghulam Mohamad Gulzar; Altaf Hussain Shah; Jaswinder Singh Sodhi; Mushtaq Ahmad Khan; Abid Shoukat; Riyaz U Saif
Journal:  Indian J Gastroenterol       Date:  2013-03-21

6.  Troxipide in the management of gastritis: a randomized comparative trial in general practice.

Authors:  Bhupesh Dewan; Aarthi Balasubramanian
Journal:  Gastroenterol Res Pract       Date:  2010-11-25       Impact factor: 2.260

7.  Lafutidine 10 mg versus Rabeprazole 20 mg in the Treatment of Patients with Heartburn-Dominant Uninvestigated Dyspepsia: A Randomized, Multicentric Trial.

Authors:  Bhupesh Dewan; Nisha Philipose
Journal:  Gastroenterol Res Pract       Date:  2011-05-05       Impact factor: 2.260

8.  Formulation and evaluation of floating oral in situ gelling system of amoxicillin.

Authors:  Dasharath M Patel; Divyesh K Patel; Chhagan N Patel
Journal:  ISRN Pharm       Date:  2011-07-28

9.  Serum prolidase activity, oxidant and antioxidant status in nonulcer dyspepsia and healthy volunteers.

Authors:  Shweta Kumari; Akhilesh Kumar Verma; Sumit Rungta; Rahul Mitra; Ragini Srivastava; Narender Kumar
Journal:  ISRN Biochem       Date:  2013-10-29

10.  Non-viable Lactobacillus reuteri DSMZ 17648 (Pylopass™) as a new approach to Helicobacter pylori control in humans.

Authors:  Heidrun Mehling; Andreas Busjahn
Journal:  Nutrients       Date:  2013-08-02       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.